Heron Therapeutics | HRTX - 净收入



金融业
股票价格
USD
资产
USD 246.22M
现金及等价物
USD 26.12M
销售成本
USD 11.12M
流动资产
USD 228.98M
流动负债
USD 90.52M
债务
USD 149.65M
股息收益率
0
EBIT
USD 38K
EBITDA
USD -3.88M
员工
126
EPS每股收益
USD -0.02
股本和储备
USD 9.14M
销售毛利
USD 29.47M
债务利息支出
USD 600K
利息收入
USD 433K
贷款资金
USD 140.64M
市值
USD 130.9M
净收入
USD -2.95M
营业费用
USD 40.55M
营业利润
USD 38K
普通股股本
USD 188.31M
税前利润
USD -2.95M
销售收入
USD 40.59M
销售和管理费用
USD 23.74M
股票
USD 54.57M
贸易债权人
USD 8.97M
应收帐款人
USD 89.59M


净收入 更改 日
ALKERMES USD -66.48M 115.82M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amarin USD -1.22M 6.51M 2025-12
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -132.73M 163.54M 2026-03
Eisai JPY -3.25B 20.43B 2026-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD 61.83M 93.16M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
Merck USD -4.24B 7.2B 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 2.92M 1.28M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Surmodics USD -5.32M 6.22M 2025-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Veracyte USD 28.71M 12.44M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03